WINTON GROUP Ltd - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$81,855
+132.9%
109,140
+14.4%
0.01%
+150.0%
Q4 2022$35,153
-7.5%
95,394
+6.8%
0.00%0.0%
Q3 2022$38,000
-49.3%
89,346
-7.5%
0.00%
-50.0%
Q2 2022$75,000
+114.3%
96,571
+256.1%
0.00%
+100.0%
Q1 2022$35,000
-25.5%
27,119
+111.4%
0.00%
+100.0%
Q4 2019$47,000
-63.6%
12,829
-12.7%
0.00%
-66.7%
Q4 2018$129,000
-57.6%
14,703
+1.5%
0.00%
-62.5%
Q2 2018$304,000
-3.2%
14,487
-25.7%
0.01%
-11.1%
Q1 2018$314,000
-90.4%
19,487
-91.6%
0.01%
-91.3%
Q3 2017$3,263,000231,9470.10%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders